BiotechTubeBiotechTube
Home/Spruce Biosciences/Saba Sile
SS

Saba Sile

Vice President, Clinical Development

Spruce Biosciences

Therapeutic Areas

Neurological DisordersEndocrine DisordersRare DiseasesLysosomal Storage Disorders

Spruce Biosciences Pipeline

DrugIndicationPhase
Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT)Mucopolysaccharidosis Type IIIB (MPS IIIB / Sanfilippo Syndrome Type B)Phase 3

Leadership Team at Spruce Biosciences

JS
Javier Szwarcberg
Chief Executive Officer
SG
Samir Gharib
President and Chief Financial Officer
KW
Kirk Ways
Chief Medical Officer
DR
Dasharatha Reddy
Vice President, Pharmaceutical Development and Manufacturing
MG
Michael Grey
Executive Chairman
PB
Percival Barretto-Ko
Independent Director
CV
Camilla V. Simpson
Independent Director
DS
Dan Spiegelman
Independent Director
KW
Keli Walbert
Independent Director
View full Spruce Biosciences profile